scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1042182338 |
P356 | DOI | 10.1186/1471-2350-6-43 |
P932 | PMC publication ID | 1326229 |
P698 | PubMed publication ID | 16351713 |
P5875 | ResearchGate publication ID | 7417701 |
P50 | author | Sebastian Suerbaum | Q2263170 |
Manfred Rohde | Q21337902 | ||
Astrid Westendorf | Q21402720 | ||
Jan Buer | Q117207046 | ||
P2093 | author name string | Robert Geffers | |
Florian Gunzer | |||
Sya N Ukena | |||
Wiebke Hansen | |||
Sina Coldewey | |||
P2860 | cites work | Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties | Q21999072 |
Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917 | Q24561803 | ||
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine | Q24685766 | ||
Toll-like receptors | Q27860671 | ||
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 | ||
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product | Q28141458 | ||
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 | Q28185796 | ||
Structure and evolution of the human IKBA gene | Q28611446 | ||
A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917 | Q30861977 | ||
Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data | Q33213936 | ||
Molecular and functional analysis of Shiga toxin–induced response patterns in human vascular endothelial cells | Q33347553 | ||
Chemokines in the inflammatory bowel diseases | Q33760184 | ||
Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization | Q33864114 | ||
Protection from gastrointestinal diseases with the use of probiotics | Q34130929 | ||
PROBIOTICS: GROWTH-PROMOTING FACTORS PRODUCED BY MICROORGANISMS. | Q34258740 | ||
Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens | Q35005200 | ||
Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC) | Q35595770 | ||
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. | Q35595783 | ||
Immunological effects of probiotics with special reference to lactobacilli | Q35600566 | ||
Probiotic and other functional microbes: from markets to mechanisms | Q36098522 | ||
Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine | Q36362784 | ||
Intestinal epithelial cells synthesize glucocorticoids and regulate T cell activation | Q36399797 | ||
Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells | Q36585466 | ||
Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells | Q40545654 | ||
Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli | Q40668288 | ||
Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. | Q40961532 | ||
Absence of HeLa cell contamination in 169 cell lines derived from human tumors | Q41761715 | ||
Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. | Q41892979 | ||
Different cytokine response of primary colonic epithelial cells to commensal bacteria. | Q41899318 | ||
Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro | Q42282244 | ||
Bacterial biofilm within diseased pancreatic and biliary tracts | Q43004569 | ||
The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. | Q44569223 | ||
Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis | Q45002113 | ||
Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing | Q45251378 | ||
Properties of Escherichia coli strains of serotype O6. | Q45290383 | ||
Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells | Q51035102 | ||
Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples | Q54530550 | ||
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 | Q59089322 | ||
Restriction of CEA synthesis to the stationary phase of growth of cultured human colon carcinoma cells | Q67811874 | ||
Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release | Q70994113 | ||
Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients | Q71046247 | ||
Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis | Q71746847 | ||
Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells | Q73322874 | ||
Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules | Q81396496 | ||
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis | Q81643904 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
probiotics | Q1816730 | ||
P304 | page(s) | 43 | |
P577 | publication date | 2005-12-13 | |
P1433 | published in | BMC Medical Genetics | Q15759918 |
P1476 | title | The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1 | |
P478 | volume | 6 |
Q37969596 | <i>Escherichia coli</i> Nissle 1917 (Mutaflor): New Insights into an Old Probiotic Bacterium |
Q90570106 | Attenuation of Intestinal Epithelial Cell Migration During Cryptosporidium parvum Infection Involves Parasite Cdg7_FLc_1030 RNA-Mediated Induction and Release of Dickkopf-1 |
Q37440890 | B cells modulate mucosal associated invariant T cell immune responses. |
Q54491141 | Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells |
Q42291122 | Computational Analysis of Host-Pathogen Protein Interactions between Humans and Different Strains of Enterohemorrhagic Escherichia coli |
Q36898718 | Current and future uses of real-time polymerase chain reaction and microarrays in the study of intestinal microbiota, and probiotic use and effectiveness |
Q54385628 | Decisive role of lipopolysaccharide in activating nitric oxide and cytokine production by the probiotic Escherichia coli strain Nissle 1917. |
Q38066574 | Developing Oral Probiotics from Streptococcus Salivarius |
Q35581546 | Disruption of Escherichia coli Nissle 1917 K5 capsule biosynthesis, through loss of distinct kfi genes, modulates interaction with intestinal epithelial cells and impact on cell health. |
Q33280033 | Impact of the rpoS genotype for acid resistance patterns of pathogenic and probiotic Escherichia coli |
Q34194823 | Infrared low-level diode laser on serum chemokine MCP-1 modulation in mice. |
Q33525401 | Metabolites produced by probiotic Lactobacilli rapidly increase glucose uptake by Caco-2 cells |
Q35157719 | Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. |
Q37299999 | Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilli |
Q34499067 | Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics |
Q64257525 | Oral administration of Lactobacillus rhamnosus GG to newborn piglets augments gut barrier function in pre-weaning piglets |
Q41518536 | Oral bacteria as potential probiotics for the pharyngeal mucosa. |
Q37320010 | Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis |
Q36629073 | Probiotics: properties, examples, and specific applications. |
Q54429291 | Regulation of the polymeric immunoglobulin receptor in intestinal epithelial cells by Enterobacteriaceae: implications for mucosal homeostasis |
Q37713374 | Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection |
Q27008261 | Role of Probiotics in health improvement, infection control and disease treatment and management |
Q39879434 | Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host |
Q54431152 | Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background |
Q43097032 | The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction |
Q39741559 | The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of Toll-like receptor 5, CD14, MyD88, and TRIF together with the induction of interleukin-8 expression via the mitogen-activated protein kinase pathway in e |
Q90224285 | The Potential Impact of Probiotics on the Gut Microbiome of Athletes |
Search more.